Products
Yanushko V.A., Nebylitsin Y.S., Klimchuk I.P.
RSPC Cardiology, Minsk Vitebsk State Medical University 4th Clinical Hospital named N.E.Savchenko, Minsk, Belarus
Evaluation of the clinical effectiveness of the phlebo-active therapy in the complex treatment of patients with chronic venous disease
Summary. Evaluation of the clinical effectiveness of the phlebo-active therapy with the use of drugs of II generation in the complex treatment of patients with chronic venous disease is presented. Depending on the treatment, patients were divided into two groups. The first group used the standard treatment regimen. In the second group of patients in a comprehensive treatment regimen were included phleboprotector and phlebotonic from the group of γ-Benzopyrone (flavonoids: diosmin hesperidin) – Normoven. Found that the use of the phlebo-active therapy in the comprehensive treatment is pathogenetically warranted. Comparative analysis with the the control group demonstrates that the use of the phlebo-active therapy resulted in a statistically significant reduction of clinical symptoms in the test group on the visual analog scale. Noted a marked reduction in the intensity of the subjective symptoms and objective measures